The proposed investigation represents an application of nuclear magnetic resonance (NMR) to the study of neoplastic diseases. These experiments will focus on F19 NMR to detect tumors and monitor their response to therapeutic maneuvers. F19 NMR has been shown to be valuable in the study of cells, membranes and fluorinated anesthetics. We intend to use a non-toxic, parentally administered perfluorochemical emulsion - Fluosol-DA - for this study. Fluosol-DA is concentrated in reticulo-endothelial organs and has been shown to accumulate in tumors. It has also been shown to be a radiosensitizing agent when used in conjunction with carbogen. We intend to take advantage of these characteristics by investigating the feasibility of detecting Fluosol-DA in tumors with F19 NMR surface coil spectroscopy and imaging, and maximizing the radiosensitization effect by optimizing tumor Fluosol-DA content. Initial studies will be aimed at defining the in-vitro and in-vitro NMR characteristics of Fluosol-DA (spectra, T1 and T2) and optimization of imaging equipment for F19 NMR. Surface coil spectroscopy will be used to study the uptake and clearance rate of Fluosol-DA in normal tissues, abscesses and tumors. Imaging studies to determine if F19 NMR can detect Fluosol-DA in tumors will also be done. The radiosensitization effect of Fluosol-DA and oxygen will be maximized by varying the quantity and schedule of Fluosol-DA administration. The effectiveness of Fluosol-DA as a radiosensitizer will be monitored by comparing Fluosol-DA content of the tumor (measured in-vivo by F19 NMR) with tumor growth delay. Tumor metabolism of 5-Fluorouracil (5FU) will be studied to determine if in-vivo metabolic profiles can predict tumor sensitivity or resistance. Preliminary data suggest that concentrations of 5-fluorodeoxyuridylate, a metabolite of 5FU, are useful in predicting tumor sensitivity.

National Institute of Health (NIH)
National Cancer Institute (NCI)
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
Application #
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Memorial Hospital for Cancer & Allied Di
New York
United States
Zip Code
Koutcher, J A; Alfieri, A A; Devitt, M L et al. (1992) Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res 52:4620-7
Ballon, D; Jakubowski, A; Gabrilove, J et al. (1991) In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy. Magn Reson Med 19:85-95
Ballon, D; Garwood, M; Koutcher, J A (1991) An analysis of the intrinsic resonance offset dependence of magnetization generated by stimulated echo pulse sequences for noncoupled spins. Magn Reson Imaging 9:569-75
Koutcher, J A; Ballon, D; Graham, M et al. (1990) 31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy. Magn Reson Med 16:19-34
Koutcher, J A; Alfieri, A A; Kornblith, A B et al. (1990) Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy. Cancer Res 50:7252-6
Koutcher, J A; Barnett, D; Kornblith, A B et al. (1990) Relationship of changes in pH and energy status to hypoxic cell fraction and hyperthermia sensitivity. Int J Radiat Oncol Biol Phys 18:1429-35
Koutcher, J A; Alfieri, A A; Barnett, D C et al. (1990) Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors. Radiat Res 121:312-9
Koutcher, J A; Fellenz, M P; Vaupel, P W et al. (1988) FSaII mouse tumor metabolic changes with different doses of glucose measured by 31P nuclear magnetic resonance. Cancer Res 48:5917-21